194 related articles for article (PubMed ID: 34678603)
1. Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors.
Uslu H; Osmaniye D; Sağlik BN; Levent S; Özkay Y; Benkli K; Kaplancikli ZA
Bioorg Chem; 2021 Dec; 117():105430. PubMed ID: 34678603
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.
Bekircan O; Danış Ö; Şahin ME; Çetin M
Bioorg Chem; 2022 Jan; 118():105493. PubMed ID: 34814086
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors.
Özdemir Z; Alagöz MA; Uslu H; Karakurt A; Erikci A; Ucar G; Uysal M
Pharmacol Rep; 2020 Jun; 72(3):692-704. PubMed ID: 32144745
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors.
Çeçen M; Oh JM; Özdemir Z; Büyüktuncel SE; Uysal M; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 Nov; 25(22):. PubMed ID: 33212876
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors.
Kumar B; Sheetal ; Mantha AK; Kumar V
Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors.
Sağlık BN; Cebeci O; Acar Çevik U; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Sep; 25(18):. PubMed ID: 32971892
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.
Ilgın S; Osmaniye D; Levent S; Sağlık BN; Acar Çevik U; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Dec; 22(12):. PubMed ID: 29232838
[TBL] [Abstract][Full Text] [Related]
8. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library.
Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S
Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and hMAO Inhibitory Screening of Novel 2-Pyrazoline Analogues.
Evranos-Aksoz B; Ucar G; Yelekci K
Comb Chem High Throughput Screen; 2017; 20(6):510-521. PubMed ID: 28474546
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro, and in silico studies of new derivatives of diphenylpiperazine scaffold: A key substructure for MAO inhibition.
El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE
Bioorg Chem; 2024 Feb; 143():107011. PubMed ID: 38061181
[TBL] [Abstract][Full Text] [Related]
11. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.
Takao K; Saito T; Chikuda D; Sugita Y
Chem Pharm Bull (Tokyo); 2016; 64(10):1499-1504. PubMed ID: 27725503
[TBL] [Abstract][Full Text] [Related]
12. Biphenylpiperazine Based MAO Inhibitors: Synthesis, Biological Evaluation, Reversibility and Molecular Modeling Studies.
El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE
Bioorg Chem; 2021 Oct; 115():105216. PubMed ID: 34352710
[TBL] [Abstract][Full Text] [Related]
13. In Silico Design, Synthesis of Hybrid Combinations: Quercetin Based MAO Inhibitors with Antioxidant Potential.
Dhiman P; Malik N; Khatkar A
Curr Top Med Chem; 2019; 19(2):156-170. PubMed ID: 30747068
[TBL] [Abstract][Full Text] [Related]
14. Novel thiazolyl-hydrazone derivatives including piperazine ring: synthesis,
Osmaniye D; Alaşan R; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2022 Mar; 77(3-4):167-175. PubMed ID: 34674410
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
16. Exploration of Umbelliferone Based Derivatives as Potent MAO Inhibitors: Dry vs. Wet Lab Evaluation.
Dhiman P; Malik N; Khatkar A
Curr Top Med Chem; 2018; 18(21):1857-1871. PubMed ID: 30430943
[TBL] [Abstract][Full Text] [Related]
17. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of oxadiazole clubbed piperazine derivatives as potential antidepressant agents.
Sahu B; Bhatia R; Kaur D; Choudhary D; Rawat R; Sharma S; Kumar B
Bioorg Chem; 2023 Jul; 136():106544. PubMed ID: 37116324
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of 2-(indolylmethylidene)-2,3-dihydro-1-benzofuran-3-one and 2-(indolyl)-4H-chromen-4-one derivatives as novel monoamine oxidases inhibitors.
Takao K; U S; Kamauchi H; Sugita Y
Bioorg Chem; 2019 Jun; 87():594-600. PubMed ID: 30933784
[TBL] [Abstract][Full Text] [Related]
20. Synthesis,
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Atlı Eklioğlu Ö; Özkay Y; Koparal AS; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1422-1432. PubMed ID: 32602377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
